XORTX THERAPEUTICS INC (XRTX) Stock Cash Flow
NASDAQ:XRTX - Nasdaq - CA98420Q3061 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -993.20K | -3.31M | -2.16M | -7.00M | -1.22M | |||
| Depreciation Amortization | 111.20K | 117.30K | 139.70K | 58.20K | 12.50K | |||
| Change In Working Capital | 710.60K | 116.80K | -1.03M | 1.47M | -964.30K | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | -2.85M | -599.40K | -3.53M | -1.98M | -2.14M | |||
| OPERATING CASH FLOW | -3.02M | -3.68M | -6.58M | -8.17M | -4.25M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -39.70K | -38.90K | -46.40K | -45.70K | -27.90K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -39.70K | -38.90K | -46.40K | -45.70K | -27.90K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -76.80K | -69.70K | -66.10K | -20.40K | N/A | |||
| Stock Issued/Repurchased | 1.61M | 3.52M | 300.00 | 5.00M | 17.73M | |||
| Other Financing Activity | -393.20K | -667.90K | -295.30K | -1.07M | -599.60K | |||
| FINANCING CASH FLOW | 1.14M | 2.78M | -361.00K | 3.91M | 17.13M | |||
| Exchange Rate Effect | -25.60K | -36.00K | 4.00K | -136.20K | 228.20K | |||
| CHANGE IN CASH | -1.94M | -974.00K | -6.99M | -4.44M | 13.08M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -3.02M | -3.68M | -6.58M | -8.17M | -4.25M | |||
| Capital Expenditure | -39.70K | -38.90K | -46.40K | -45.70K | -27.90K | |||
| FREE CASH FLOW | -3.06M | -3.72M | -6.63M | -8.21M | -4.27M | |||
All data in USD